These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 28506857

  • 1. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.
    Lin MF, Yang YF, Peng ZP, Zhang MF, Liang JY, Chen W, Liu XH, Zheng YL.
    Int J Biochem Cell Biol; 2017 Jul; 88():155-161. PubMed ID: 28506857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
    Yan TH, Qiu C, Sun J, Li WH.
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 10. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 26; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 11. miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.
    Su SG, Yang M, Zhang MF, Peng QZ, Li MY, Liu LP, Bao SY.
    Int J Biochem Cell Biol; 2017 Oct 26; 91(Pt A):53-59. PubMed ID: 28867541
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
    Zhao Z, Gao J, Huang S.
    Dig Dis Sci; 2022 Mar 26; 67(3):925-935. PubMed ID: 33738672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J, Xu T, Wang F, Cai W, Chen L.
    Biomed Pharmacother; 2017 Jun 26; 90():744-751. PubMed ID: 28419971
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J, Zhang Y, Guo Y, Yu C, Chen M, Li Z, Tian S, Sun C.
    Oncotarget; 2015 Mar 20; 6(8):6359-72. PubMed ID: 25849943
    [Abstract] [Full Text] [Related]

  • 18. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
    Tian QH, Zhang MF, Zeng JS, Luo RG, Wen Y, Chen J, Gan LG, Xiong JP.
    J Mol Med (Berl); 2019 Nov 20; 97(11):1535-1545. PubMed ID: 31463732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 20; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.